Letter to the Editor

Vol. 8 No. 2 (2021): European Journal of Rheumatology
DOI: https://doi.org/10.5152/eurjrheum.2020.20080

Article Sidebar

Full Text PDF
Published: Apr 1, 2021
Keywords:
AVES Editorial Office

Main Article Content

Andrea Becciolini
Department of Medicine, Unit of Internal Medicine and Rheumatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
Federica Lumetti
Department of Medicine, Unit of Internal Medicine and Rheumatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
Eleonora Di Donato
Department of Medicine, Unit of Internal Medicine and Rheumatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
Salvatore Giordano
Department of Medicine, Unit of Internal Medicine and Rheumatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
Daniele Santilli
Department of Medicine, Unit of Internal Medicine and Rheumatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
Flavio Mozzani
Department of Medicine, Unit of Internal Medicine and Rheumatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
Michele Riva
Department of Medicine, Unit of Internal Medicine and Rheumatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
Gianluca Lucchini
Department of Medicine, Unit of Internal Medicine and Rheumatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
Alarico Ariani
Department of Medicine, Unit of Internal Medicine and Rheumatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy

bDMARDs retention rate in the biosimilar era: A real-life monocentric study

Main Article Content

Andrea Becciolini
Department of Medicine, Unit of Internal Medicine and Rheumatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
Federica Lumetti
Department of Medicine, Unit of Internal Medicine and Rheumatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
Eleonora Di Donato
Department of Medicine, Unit of Internal Medicine and Rheumatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
Salvatore Giordano
Department of Medicine, Unit of Internal Medicine and Rheumatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
Daniele Santilli
Department of Medicine, Unit of Internal Medicine and Rheumatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
Flavio Mozzani
Department of Medicine, Unit of Internal Medicine and Rheumatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
Michele Riva
Department of Medicine, Unit of Internal Medicine and Rheumatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
Gianluca Lucchini
Department of Medicine, Unit of Internal Medicine and Rheumatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
Alarico Ariani
Department of Medicine, Unit of Internal Medicine and Rheumatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy

Abstract

Cite this article as: Becciolini A, Lumetti F, Di Donato E, Giordano S, Santilli D, Mozzani F, et al. bDMARDs retention rate in the biosimilar era: a real-life monocentric study. Eur J Rheumatol 2021; 8(2): 109-10.


Article Details